Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

AUSTRALIA: New Hepatitis C Treatment Available in Australia


Australian Associated Press (02.01.12) - Thursday, February

The new hepatitis C drug Victrelis (boceprevir) recently won approval by Australia's Therapeutic Goods Administration. Scientists report the protease inhibitor is effective against hepatitis C genotype 1.

"In the last 10 years, there has been little development in the availability of treatments for hepatitis C, and a significant proportion of patients fail to respond to current standard of care," said a statement from Professor Geoff McCaughan, director of the AW Morrow Gastroenterology and Liver Center in Sydney. "Victrelis is an approved treatment that works directly on the hepatitis C virus and prevents it from replicating and therefore reproducing." An estimated 200,000 Australians are infected with hepatitis C, and 20,000 new cases are reported each year. "Hepatitis C is a huge burden for individuals and is still very heavily stigmatized, and having another new treatment option marks progress in the management of patients with the disease," said McCaughan.

At its meeting in March, the Pharmaceutical Benefits Scheme Committee is set to consider whether to list the drug.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in February 2, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.